semaglutide
-
Biocon signs agreement for generic Ozempic commercialisation in Brazil with Biomm
Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory…
Read More » -
Novo Nordisk India launches GLP-1 RA, Oral Semaglutide, to treat diabetes
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…
Read More »